Medicinal Chemistry of Small Molecule CCR5 Antagonists for Blocking HIV-1 Entry: A Review of Structural Evolution

Author(s): Ye Tian, Dujuan Zhang, Peng Zhan, Xinyong Liu

Journal Name: Current Topics in Medicinal Chemistry

Volume 14 , Issue 13 , 2014

Become EABM
Become Reviewer
Call for Editor

Graphical Abstract:


CCR5, a member of G protein-coupled receptors superfamily, plays an important role in the HIV-1 entry process. Antagonism of this receptor finally leads to the inhibition of R5 strains of HIV entry into the human cells. The identification of CCR5 antagonists as antiviral agents will provide more option for HAART. Now, more than a decade after the first small molecule CCR5 inhibitor was discovered, great achievements have been made. In this article, we will give a brief introduction of several series of small molecule CCR5 antagonists, focused on their appealing structure evolution, essential SAR information and thereof the enlightenment of strategies on CCR5 inhibitors design.

Keywords: Anti-HIV-1, CCR5 antagonists, drug design, SAR, small molecule, structural evolution.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2014
Published on: 06 August, 2014
Page: [1515 - 1538]
Pages: 24
DOI: 10.2174/1568026614666140827143934
Price: $65

Article Metrics

PDF: 44